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Summary
Introduction:  Giant  cell  tumors  (GCT)  of  the  hand  are  relatively  common  and  have  a  good
prognosis,  but  the  risk  of  recurrence  is  high.  The  goal  of  this  study  was  to  evaluate  the  long-
term clinical  results  of  a  consecutive  series  of  patients  and  to  determine  the  risk  factors  for
recurrence.
Material and  methods:  This  was  a  retrospective  study  of  96  patients  (57  women,  39  men)
operated between  February  1982  and  October  2005  for  GCT  of  the  tendon  sheaths  in  the  hand.
The average  age  at  the  time  of  the  procedure  was  47.7  ±  14.5  years  (range  13—75).  All  the
patients were  reviewed  by  an  independent  surgeon.  The  following  were  recorded:  clinical  result
(QuickDASH,  satisfaction),  recurrence,  histological  appearance  of  tumor,  location  of  tumor,
excision margins  and  extension  into  the  neighboring  anatomical  structures  (tendon,  joint).  The
tumor was  located  in  the  index  ﬁnger  in  29  cases,  middle  ﬁnger  in  23  cases,  thumb  in  21
cases, ring  ﬁnger  in  11  cases,  little  ﬁnger  in  11  cases,  hypothenar  area  in  two  cases  and  thenar
area in  one  case.  In  all  cases,  the  lesion  was  isolated.  The  swelling  was  palmar  in  27  cases,
dorsal in  20  cases  and  medial  or  lateral  in  59  cases.  The  most  common  joint  location  was
the DIP  joint  (35%  of  cases).  The  swollen  area  was  sensitive  in  12  cases.  The  time  from  the
appearance  of  the  tumor  to  physician  consultation  ranged  between  1  month  and  7  years.  Before
the surgery,  standard  X-rays  were  taken  in  all  patients;  ultrasonography  was  also  performed  in
eight patients  and  MRI  in  one  patient.  The  tumor  had  an  average  diameter  of  15.8  ±  2.6  mm
(range 5—30).  Histological  analysis  revealed  a  multilobed  lesion  with  multinucleated  giant  cells,
with or  without  encapsulation.
Results:  The  average  follow-up  at  the  time  of  review  was  12.1  ±  3.8  years  (range  5—29).  There
were eight  recurrences  in  seven  patients  (8.3%).  The  average  time  to  recurrence  was  2.75  ±  2
years (range  1—6.5).  In  every  case  of  recurrence,  there  had  been  intra-articular  tumor  devel-
opment and/or  tendon  destruction  (P  <  0.01).  There  was  one  functional  complication:  one  DIP
joint fusion  secondary  to  one  of  the  recurrences.  The  average  QuickDASH  was  2.3/100  (range
0—31).
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Conclusion:  Giant  cell  tumors  of  the  synovial  sheaths  in  the  hand  are  benign  lesions  where
recurrence  is  the  primary  risk.  The  recurrence  typically  occurred  within  36  months  of  the  exci-
sion. Intra-articular  tumor  development,  marginal  resection  and  tendon  involvement  seem  to
contribute  to  recurrence.  There  was  no  correlation  found  between  the  histological  type  of
tumor (encapsulated  or  not)  and  recurrence.
Level  of  proof:  IV.
.  All  rights  reserved.
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Results
The  average  follow-up  was  12.1  ±  3.8  years  (range  5—29)
(Table  2).
There  were  eight  recurrences  in  seven  patients
(one  patient  had  two  recurrences  despite  the  surgical© 2013  Elsevier  Masson  SAS
ntroduction
iant  cell  tumors  (GCTs)  of  the  tendon  sheaths  in  the  hand
re  benign  tumors  that  can  invade  the  soft  tissues  of  the
and  and  also  the  joints.  These  are  one  of  the  most  common
umors  of  the  hand,  after  synovial  cysts  [1].  GCTs  have  also
een  called  myeloplax  tumors,  ﬁbrous  xanthoma,  myelox-
nthoma  [2],  and  pigmented  villonodularsynovitis  [3].  The
atter  mostly  involves  large  joints  (knee,  hip).  All  these
amed  tumors  have  the  same  histological  criterion:  the
resence  of  multinucleated  giant  cells.  Although  giant  cell
umors  (GCT)  are  considered  benign  and  have  a  good  prog-
osis,  they  have  a  high  risk  of  recurrence  [4—7].  The  goal
f  this  study  was  to  evaluate  long-term  clinical  results  and
etermine  risk  factors  for  recurrence.
aterial and methods
his  was  a  retrospective  study  with  96  patients  (57  women,
9  men)  presenting  a  GCT  of  the  tendon  sheaths  in  the  hand
nd  operated  between  February  1982  and  October  2005.  The
verage  age  at  the  time  of  the  procedure  was  47  ±  15  years
range  13—75).
All  the  patients  were  evaluated  again  by  an  indepen-
ent  surgeon.  A  clinical  questionnaire  was  completed  over
he  telephone,  as  were  the  QuickDASH  and  a  satisfaction
uestionnaire.
Statistical  testing  was  performed  with  a  Fisher’s  Exact
est.
Before  the  surgery,  standard  A/P  and  lateral  X-rays
irectly  over  the  tumor  were  performed  systematically.
ltrasonography  was  also  performed  in  eight  patients  and
agnetic  resonance  image  (MRI)  in  one  patient.
The  surgical  procedure  was  performed  on  an  outpatient
asis  using  regional  anesthesia.  A  brachial  tourniquet  was
sed  systematically  and  the  procedure  was  carried  out  with
urgical  loupes.
The  lesion  was  found  in  the  index  in  29  cases,  middle
nger  in  23,  thumb  in  21,  ring  ﬁnger  in  11,  little  ﬁnger  in  11,
ypothenar  area  in  two  and  thenar  area  in  one  (Fig.  1).  The
ost  common  GCT  joint  location  was  the  DIP  joint  (35%  of
ases).  The  swelling  was  palmar  only  in  28%  of  cases,  dorsal
n  21%  and  medial  or  lateral  in  51%  of  cases.
In  13.5%,  an  injury  to  the  area  had  preceded  the  appear-
nce  of  the  lesion.
The  time  from  the  tumor  appearance  to  physician  consul-
ation  ranged  between  1  month  and  7  years.The  swollen  area  was  sensitive  in  12.5%  of  cases.
No  other  lesion  was  found  on  X-rays  in  80  cases.  Cortical
eformation  was  visible  in  ﬁve  cases  and  subchondral  cysts
n  11  cases  (Fig.  2).Figure  1  Distribution  of  tumors  in  the  hand.
The  ultrasonography  assessment  showed  a  hypoe-
hogenic  image  that  was  not  hypervascularized;  the  MRI
howed  a  tissue  with  little  gadolinium  uptake.
The  average  size  of  the  lesion  was  15.8  ±  2.6  mm  (range
—30)  determined  by  histological  analysis.  The  lesion  was
ncapsulated  in  96%  of  cases.  The  tumor  was  multinodu-
ar  in  62.5%  of  cases  (Fig.  3)  and  was  nodular  in  47.5%
f  cases.  Multinucleated  giant  cells  were  found  in  100%  of
ases.  Other  cells  such  as  histiocytes  and  siderophages  were
lso  found  (Table  1).Figure  2  Subchondral  cysts.
Giant  cell  tumors  in  the  hand  
Figure  3  Multinodular  lesion.
Table  1  Description  of  lesion.
Previous  injury 13.5%
Tumor  sensitivity 12.5%
Lesions  visible  on  X-rays  (n) 16
Average  size  (mm) 15.8
Most  common  joint  localization PIP
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(Capsule  96%
Multinodular  lesion 62.5%
treatment).  The  average  time  to  recurrence  was  2.75  years
(range  1—6.5).
There  were  two  main,  signiﬁcant  factors  for  the  risk  of
recurrence:
•  intra-articular  lesion  (P  =  0.002);
•  tendon  erosion  (P  =  0.01).
Three  other  factors  increased  the  risk,  but  not  signiﬁ-
cantly:
•  circumferential  lesion  (P  =  0.15);
•  multinodular  lesions  (P  =  0.12);
• marginal  excision  (P  =  0.26).
There  were  12  patients  with  sequelae:  six  cases  of  stiff-
ness  with  one  patient  requiring  distal  interphalangeal  joint
fusion  and  six  cases  of  neurological  sequelae  such  as  pares-
thesia  or  hypoesthesia.  The  QuickDASH  was  2.3/100  (range
0—31).Upon  being  asked,  80%  of  patients  indicated  they  were
very  satisﬁed,  19%  were  satisﬁed  and  1%  were  partially  sat-
isﬁed  with  the  outcome.
Table  2  Results.
Number  of  patients  96
Average  age  (years)  47
Average  follow-up  (years)  12
Recurrences  (Number  +  %)  8  (8.3%)
Delay  to  recurrence  (years)  2.75
Sequelae  (Number  +  %)  12  (12.5%)
DASH  at  follow-up  (/100)  2.3
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iscussion
CTs  of  the  tendon  sheaths  of  the  hand  are  one  of  the  more
ommon  soft  tissue  tumors  in  the  hand  after  synovial  cysts
1,8].  Its  multiple  names  have  been  a  hindrance  to  its  def-
nition.  It  was  ﬁrst  described  in  1852  by  Chassaignac  [9]
ho  called  it,  ‘‘malignant  tumor  of  the  tendon  sheaths’’.
hen  several  other  names  were  given  to  this  tumor,  such  as
‘myeloma  of  the  tendon  sheaths’’  or  ‘‘myeloxanthoma’’
2]. The  name  ‘‘giant  cell  tumor  of  the  tendon  sheath’’
as  introduced  by  Targett  [10]  and  the  name  ‘‘pigmented
odular  synovitis’’  by  Jaffe  et  al.  [3].
We  found  that  GCTs  mostly  involve  the  ﬁrst  three  ﬁngers,
ith  the  index  being  most  often  involved,  which  is  consistent
ith  published  data  [4,8].
The  patients  had  an  average  age  of  47.7  years  when
he  tumor  was  discovered.  This  was  also  consistent  with
ublished  data  reporting  that  this  tumor  mostly  affects
iddle-aged  adults  [11,12]  However,  we  had  a  13  year-old
atient  in  our  series  who  presented  with  GCT  but  no  recur-
ence.  GCT  is  rarer  in  children  [13—15].
Before  surgery,  a  standard  X-ray  directly  over  the  lesion
hould  be  performed  [16]. Other  than  providing  an  oppor-
unity  to  eliminate  differential  diagnoses,  this  will  help
o  discover  other  lesions  such  as  cortical  erosion  and
ubchondral  cysts  [7,17]. Ultrasonography  usually  detects
 hypoechogenic  lesion  [18,19],  although  hyperechogenic
ave  also  been  described  [18,20,21]. MRI  shows  an  low-
ignal  lesion,  mostly  in  the  tissue  [17,21].
Our  96  patient  series  revealed  that  GCTs  are  benign
umors  that  can  recur.  There  was  an  8.3%  recurrence  rate.
his  rate  was  low  in  comparison  to  certain  publications  that
escribed  a 30%  rate  [4—7]. Williams  [22]  found  a  12.6%
ecurrence  rate  in  a  series  of  213  patients  and  an  aver-
ge  follow-up  of  51  months.  Al  Qattan  [23]  found  an  11.6%
ecurrence  rate  in  a  series  of  43  patients  with  an  average
ollow-up  of  48  months.  Looi  et  al.  [11]  described  a  7%  recur-
ence  rate  in  his  series  with  a  follow-up  of  up  to  60  months.
n  comparison,  our  study  had  a  lengthy  average  follow-up
nd  most  of  the  recurrences  appeared  within  3  years.  How-
ver,  there  was  one  recurrence  at  78  months.
We  found  two  parameters  that  were  signiﬁcantly  related
o  recurrence  —  extension  of  the  lesion  into  the  intra-
rticular  space  (P  =  0.002)  (Fig.  4)  and  tendon  erosion  or
nvasion  (P  =  0.01).  Williams  [22]  had  also  noted  that  these
wo  factors  were  indicative  of  a  high  risk  of  recurrence
10%).  We  found  other  factors  that  were  more  common  in
ecurring  GCT  in  our  series,  although  they  were  not  sig-
iﬁcant  predictors  of  recurrence:  circumferential  lesion,
ultinodular  lesion,  marginal  excision.  Others  studies  have
hown  an  increased  risk  of  recurrence  for  non-encapsulated
umors  [4,23].  In  our  series,  we  found  no  evidence  of  cel-
ular  factors  in  recurrence,  in  contrast  to  other  studies  that
howed  the  existence  of  elevated  mitosis  [24]  and  hypercel-
ularity  [1,25].
One  of  our  patients  had  two  recurrences,  3  years  apart
ach  time,  despite  complete  excision  and  wide  margins.
lso,  during  the  second  recurrence  a  second  tumor  location
as  found  (thumb  interphalangeal  joint  and  ﬁrst  phalanx
f  ring  ﬁnger).  No  other  speciﬁc  factors,  other  than  intra-
rticular  localization  and  tendon  erosion  were  found.  At  the
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[Figure  4  Intra-articular  lesion.
ast  follow-up  of  this  patient  16  years  later,  there  had  been
o  other  recurrences.  This  double  recurrence  had  not  been
escribed  in  published  studies.
None  of  our  patients  required  additional  treatment.
lthough  complete  excision  seems  to  be  the  best  way  to
educe  the  recurrence  rate  [1,11,26],  some  have  suggested
hat  postoperative  radiation  therapy  could  be  effective  in
reventing  recurrence  [3,8]  when  risk  factors  are  present
r  excision  is  incomplete.  For  example,  the  recurrence  rate
as  reduced  to  4%  in  the  Kotwal  study.
Although  this  is  a  benign  tumor,  it  can  lead  to  seque-
ae.  We  found  a  12.5%  rate  of  sequelae,  which  is  consistent
ith  other  reports  [27].  Six  of  our  patients  presented  with
yesthesia  at  the  ﬁnal  follow-up  and  six  others  had  joint
tiffness,  which  required  PIP  fusion  in  one  patient.
onclusion
CTs  of  the  tendon  sheaths  in  the  hand  are  a  common  tumor.
hey  have  a  risk  recurrence  (8.3%  in  our  series)  that  cannot
e  ignored.  As  a  consequence,  the  patient  must  be  informed
f  the  possibility  of  this  risk,  even  in  cases  of  complete  exci-
ion,  and  especially  if  the  tumor  extends  into  the  joint  or
nvades  the  tendons.
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